Ask AI

Not Just for Kids: Spotlight on RSV in Older Adults

Join the experts to learn about the severe clinical manifestations caused by respiratory syncytial virus in older patients. Diagnostic challenges recent adult vaccine safety and efficacy data and barriers to adult vaccine implementation in primary care settings will be presented. Watch the on-demand webinar download the slides and read the companion expert-authored ClinicalThought commentaries.

Share

Program Content

Activities

RSV in Older Adults
Addressing RSV in Older Adults
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 19, 2022

Overcoming Vaccine Barriers
If RSV Vaccines Are Approved for Older Adults, What’s Next?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 17, 2022

RSV Vaccine Updates
RSV Vaccine Updates From IDWeek 2022
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 23, 2022

Activities

RSV Vaccine FAQs
If RSV Vaccines Are Approved for Older Adults, What’s Next?
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 03, 2022

No activities added yet

Activities

Slides: RSV in Adults
Not Just for Kids: Spotlight on RSV in Older Adults
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 12, 2022

ExpressPoints: RSV in Adults
ExpressPoints: RSV in Older Adults
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 24, 2022

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Janssen Therapeutics Division of Janssen Products